Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323312933> ?p ?o ?g. }
- W4323312933 endingPage "507" @default.
- W4323312933 startingPage "507" @default.
- W4323312933 abstract "The immune response elicited by the current COVID-19 vaccinations declines with time, especially among the immunocompromised population. Furthermore, the emergence of novel SARS-CoV-2 variants, particularly the Omicron variant, has raised serious concerns about the efficacy of currently available vaccines in protecting the most vulnerable people. Several studies have reported that vaccinated people get breakthrough infections amid COVID-19 cases. So far, five variants of concern (VOCs) have been reported, resulting in successive waves of infection. These variants have shown a variable amount of resistance towards the neutralising antibodies (nAbs) elicited either through natural infection or the vaccination. The spike (S) protein, membrane (M) protein, and envelope (E) protein on the viral surface envelope and the N-nucleocapsid protein in the core of the ribonucleoprotein are the major structural vaccine target proteins against COVID-19. Among these targets, S Protein has been extensively exploited to generate effective vaccines against COVID-19. Hence, amid the emergence of novel variants of SARS-CoV-2, we have discussed their impact on currently available vaccines. We have also discussed the potential roles of S Protein in the development of novel vaccination approaches to contain the negative consequences of the variants' emergence and acquisition of mutations in the S Protein of SARS-CoV-2. Moreover, the implications of SARS-CoV-2's structural proteins were also discussed in terms of their variable potential to elicit an effective amount of immune response." @default.
- W4323312933 created "2023-03-07" @default.
- W4323312933 creator A5009250229 @default.
- W4323312933 creator A5013392812 @default.
- W4323312933 creator A5013983184 @default.
- W4323312933 creator A5022201674 @default.
- W4323312933 creator A5024561569 @default.
- W4323312933 creator A5029851532 @default.
- W4323312933 creator A5032157188 @default.
- W4323312933 creator A5034081219 @default.
- W4323312933 creator A5037376006 @default.
- W4323312933 creator A5042664334 @default.
- W4323312933 creator A5043907050 @default.
- W4323312933 creator A5050220844 @default.
- W4323312933 creator A5051459366 @default.
- W4323312933 creator A5056155008 @default.
- W4323312933 creator A5060037815 @default.
- W4323312933 creator A5070617322 @default.
- W4323312933 creator A5071786572 @default.
- W4323312933 creator A5077693787 @default.
- W4323312933 creator A5077911757 @default.
- W4323312933 creator A5088568122 @default.
- W4323312933 creator A5089255069 @default.
- W4323312933 creator A5006547401 @default.
- W4323312933 date "2023-03-05" @default.
- W4323312933 modified "2023-10-16" @default.
- W4323312933 title "Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences" @default.
- W4323312933 cites W1515031832 @default.
- W4323312933 cites W1517000857 @default.
- W4323312933 cites W1585780906 @default.
- W4323312933 cites W1624339661 @default.
- W4323312933 cites W1986839001 @default.
- W4323312933 cites W1999286338 @default.
- W4323312933 cites W2006286994 @default.
- W4323312933 cites W2025977980 @default.
- W4323312933 cites W2026618142 @default.
- W4323312933 cites W2029763364 @default.
- W4323312933 cites W2037716748 @default.
- W4323312933 cites W2039860069 @default.
- W4323312933 cites W2046016450 @default.
- W4323312933 cites W2081861008 @default.
- W4323312933 cites W2102619382 @default.
- W4323312933 cites W2105626573 @default.
- W4323312933 cites W2119248683 @default.
- W4323312933 cites W2119494556 @default.
- W4323312933 cites W2127106192 @default.
- W4323312933 cites W2151847720 @default.
- W4323312933 cites W2166737662 @default.
- W4323312933 cites W2325881814 @default.
- W4323312933 cites W2394751260 @default.
- W4323312933 cites W2418601731 @default.
- W4323312933 cites W2554383504 @default.
- W4323312933 cites W2555838982 @default.
- W4323312933 cites W2563443345 @default.
- W4323312933 cites W2588593853 @default.
- W4323312933 cites W2750464792 @default.
- W4323312933 cites W2753483322 @default.
- W4323312933 cites W2777057590 @default.
- W4323312933 cites W2782708334 @default.
- W4323312933 cites W2800054253 @default.
- W4323312933 cites W2872999080 @default.
- W4323312933 cites W2891536860 @default.
- W4323312933 cites W2909269082 @default.
- W4323312933 cites W2961994201 @default.
- W4323312933 cites W2975856930 @default.
- W4323312933 cites W3009335299 @default.
- W4323312933 cites W3009440878 @default.
- W4323312933 cites W3014067025 @default.
- W4323312933 cites W3015704123 @default.
- W4323312933 cites W3020076836 @default.
- W4323312933 cites W3023376619 @default.
- W4323312933 cites W3024602798 @default.
- W4323312933 cites W3025987322 @default.
- W4323312933 cites W3029682964 @default.
- W4323312933 cites W3032255042 @default.
- W4323312933 cites W3033295933 @default.
- W4323312933 cites W3034202401 @default.
- W4323312933 cites W3034425032 @default.
- W4323312933 cites W3034680516 @default.
- W4323312933 cites W3034816694 @default.
- W4323312933 cites W3035459690 @default.
- W4323312933 cites W3036386821 @default.
- W4323312933 cites W3036529319 @default.
- W4323312933 cites W3036607916 @default.
- W4323312933 cites W3037923073 @default.
- W4323312933 cites W3039692269 @default.
- W4323312933 cites W3039901154 @default.
- W4323312933 cites W3040540914 @default.
- W4323312933 cites W3041450977 @default.
- W4323312933 cites W3042323010 @default.
- W4323312933 cites W3042332408 @default.
- W4323312933 cites W3043408867 @default.
- W4323312933 cites W3043991892 @default.
- W4323312933 cites W3044660350 @default.
- W4323312933 cites W3044914269 @default.
- W4323312933 cites W3045578670 @default.
- W4323312933 cites W3045734160 @default.
- W4323312933 cites W3045870925 @default.